The past year has been of great progress in AMYPAD, and major milestones were achieved for the AMYPAD Diagnostic and Patient Management Study (DPMS) and the Prognostic and Natural History Study (PNHS). Both protocols were accepted and studies recruited their first participants.

If you are interested to receive the latest AMYPAD news, click here to subscribe to our quarterly newsletter.

Check out the two videos below to learn more about the DPMS and PNHS studies.

Interview with Giovanni Frisoni from UNIGE (WP3 leader) about the DPMS study

Interview with Craig Ritchie from UEDIN (WP4 leader) about the PNHS study